Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Breaking News

Investigation of Contraception Given to Ethiopian Women To Be Launched

State Comptroller Yosef Shapira announced on Sunday he would launch a probe into the allegations that Ethiopian women who sought to immigrate to Israel were administered the long-acting contraceptive Depo-Provera with the intent of reducing birthrate within Ethiopian community.

The comptroller’s announcement said that “it is possible that some of the women did not understand” what was at stake when they received the shots. The comptroller went on to explain that the decision to examine the use of Depo-Provera came in response to “appeals by female Knesset members, headed by chairman of the Knesset Committee on the Rights of the Child Orly Levi-Abekasis.”

A special division within the comptroller’s office will lead the investigation, and an additional commission will be established to look into the practice if needed.

Levi-Abekasis and several other Knesset members turned to the comptroller following a report by the Knesset Research and Information Center regarding widespread use of the injections in the transit camps in Ethiopia. The report revealed that a vast majority of women who took part in family planning workshops in the camps received the contraceptive shots. The study by the Knesset research institute presents worrying data about the conduct of the state in the transit camps.

Read more at Haaretz.com.

A message from our CEO & publisher Rachel Fishman Feddersen

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

We’ve set a goal to raise $260,000 by December 31. That’s an ambitious goal, but one that will give us the resources we need to invest in the high quality news, opinion, analysis and cultural coverage that isn’t available anywhere else.

If you feel inspired to make an impact, now is the time to give something back. Join us as a member at your most generous level.

—  Rachel Fishman Feddersen, Publisher and CEO

With your support, we’ll be ready for whatever 2025 brings.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at editorial@forward.com, subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.

Exit mobile version